FIELD: medicine.
SUBSTANCE: invention provides a method for prediction of formation of chronic lymphotic leukaemia and onset development of combined complications involving DNA recovery from the peripheral venous blood, differing by the fact that type 2 tumour necrosis factor receptor gene polymorphism (+1663 A/G TNFR2) is analysed to predict a high risk of formation of chronic lymphotic leukaemia and onset development of combined complications if detecting the +1663 G TNFR2 allele.
EFFECT: early detection of the disease.
1 ex, 3 tbl, 1 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF CLINICAL COURSE AND TREATMENT EFFICACY OF TYPE 2 DIABETES MELLITUS | 2013 |
|
RU2533286C1 |
| METHOD FOR PREDICTION OF OVERALL SURVIVAL IN PATIENTS WITH CHRONIC LYMPHATIC LEUKAEMIA | 2012 |
|
RU2498313C1 |
| METHOD FOR PREDICTION OF RISK OF THROMBOCYTOPENIA DEVELOPMENT ACCOMPANYING CLINICAL COURSE OF CHRONIC LYMPHATIC LEUKAEMIA | 2012 |
|
RU2508543C1 |
| METHOD FOR PREDICTION OF MODERATE SEVERITY OF CHRONIC TRUE ECZEMA | 2014 |
|
RU2578441C1 |
| METHOD FOR PREDICTING RISK OF DEVELOPING CHRONIC TRUE ECZEMA IN INDIVIDUALS DEPENDING ON AVAILABILITY OF FAMILY HISTORY | 2014 |
|
RU2585382C1 |
| METHOD FOR PREDICTION RISK OF DEVELOPMENT OF DIABETIC ANGIOPATHY OF LOWER EXTREMITIES IN PATIENTS SUFFERING TYPE 2 DIABETES MELLITUS | 2012 |
|
RU2507520C1 |
| METHOD FOR PREDICTION OF RISK OF DEVELOPING PRIMARY OPEN-ANGLE GLAUCOMA IN INDIVIDUALS DEPENDING ON PRESENCE/ABSENCE OF COMORBIDITY OF EYES | 2014 |
|
RU2597784C2 |
| METHOD FOR PREDICTION OF RISK OF SUB-ACUTE STAGE OF CHRONIC IDIOPATHIC ECZEMA | 2014 |
|
RU2572338C1 |
| METHOD FOR PREDICTION OF GLYCOSYLATED HAEMOGLOBIN IN PATIENTS SUFFERING FROM DIABETES MELLITUS TYPE 2 | 2013 |
|
RU2533456C1 |
| METHOD FOR PREDICTION OF SMOULDERING FORM OF CHRONIC LYMPHOLEUKAEMIA | 2012 |
|
RU2496110C1 |
